New appointment at Aileron Therapeutics
This article was originally published in Scrip
Executive Summary
Aileron Therapeutics, a US biotechnology company discovering and developing a class of therapeutics called stapled peptides, has appointed Dr Steven Kafka as its first chief financial officer and vice-president of finance and operations. He joins from Infinity Pharmaceuticals, where he served as vice-president of finance.